<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>13</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2008</Year><Month>02</Month><Day>07</Day></PubDate></Journal><title locale="en_US">Effect of trazodone on sleep bruxism in children and adolescents 6-18 years of age, a pilot study</title><FirstPage>29</FirstPage><LastPage>33</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Psychiatry, Alzahra Hospital, Isfahan University of Medical Sciences (IUMS).</affiliation></Author><Author><affiliation locale="en_US">Student Research Committee, Isfahan University of Medical Sciences.</affiliation></Author><Author><affiliation locale="en_US">Department of Psychiatry, Alzahra Hospital, Isfahan University of Medical Sciences.</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2007</Year><Month>07</Month><Day>09</Day></PubDate><PubDate PubStatus="accepted"><Year>2007</Year><Month>12</Month><Day>30</Day></PubDate></History><abstract locale="en_US">&lt;ul&gt;   &lt;li&gt;&lt;strong&gt;BACKGROUND&lt;/strong&gt;: Sleep bruxism is a common sleep disorder with unclear etiology and no definitive treatment. Recent&lt;/li&gt;   &lt;li&gt;suggested medications are not often practically used due to their numerous limitations. Based on the fact that sleep bruxism occurs most often in the second stage of non-REM sleep, this study aimed to assess the effect of trazodone on sleep bruxism.&lt;strong&gt; &lt;br /&gt;     &lt;/strong&gt;&lt;/li&gt;   &lt;li&gt;&lt;strong&gt;METHODS&lt;/strong&gt;: This pilot study was conducted as a before-after design on 28 children and adolescents with 6-18 years of age suffering from sleep bruxism referring by children and adolescents mental health clinic, children dental specialists and pediatricians. The treatment started with 0.5mg/kg/day. In non-responders, it was weekly added by 0.5 mg/kg/day (with optimum of 2 mg/kg/day). Frequency of bruxism and related morning face/jaw pain were assessed daily from two weeks before (baseline) to four weeks after starting the intervention by the parents/roommate.&lt;/li&gt;   &lt;li&gt;&lt;strong&gt;RESULTS&lt;/strong&gt;: Findings showed a significant reduction in the frequency of both bruxism and related morning pain from baseline to the 2nd and the 4th weeks of the intervention (P&amp;lt;0.001). Minor side effects such as drowsiness, nausea and dry mouth were seen among approximately one-third of the patients. These side effects were self-limited and tolerable.&lt;/li&gt;   &lt;li&gt;&lt;strong&gt;CONCLUSIONS: &lt;/strong&gt;Trazodone could be effective in reducing the frequency of sleep bruxism and its related morning face/jaw pain. Well-designed placebo-controlled trials are needed to confirm the results.&lt;/li&gt;   &lt;li&gt;&lt;strong&gt;KEY WORDS&lt;/strong&gt;: Sleep bruxism, trazodone, teeth clenching, teeth grinding.&lt;/li&gt; &lt;/ul&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/1127</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/1127/658</pdf_url></Article></Articles>
